Article
Approximately 30 million people are afflicted with chronic sinusitis annually. Many can be successfully treated with antibiotics but for those who cannot, surgery is often recommended.
Outlook Therapeutics completes analysis of 12-week safety and efficacy results of NORSE EIGHT
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
How food choices may affect non-refractive visual impairment
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
RhyGaze secures Series A financing of $86 million to further novel gene therapy
Ashvattha Therapeutics secures $50M in financing to advance clinical trials